The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg

Journal of Internal Medicine

Volumn 247, Issue 5, 2000, Pages 601-606

  Lindmarker, P ^a   Schulman, S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Contralateral; Follow up; Ipsilateral; Recurrence; Venous thrombosis

Indexed keywords

ANTIVITAMIN K;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; LEG PHLEBOGRAPHY; LEG THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; THROMBOEMBOLISM; VEIN BLOOD FLOW;

AGED; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEG; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECURRENCE; RISK; SWEDEN; TREATMENT OUTCOME; VENOUS THROMBOSIS; VITAMIN K;

EID: 0034030810     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00662.x     Document Type: Article

References (21)

1. 1 Rosendaal F. Thrombosis in the young: Epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997; 78: 1-6.
2. 2 Søgaard Andersen B, Steffensen FH, Soørensen HF, Nielsen GL, Olsen J. The cumulative incidence of venous thromboembolism during pregnancy and puerperium. Acta Obstet Gynecol Scand 1998; 77: 170-3.
3. 3 Soøgaard Andersen B, Olsen J. Oral contraception and factor Leiden mutation in relation to localization of deep vein thrombosis. Thromb Res 1998; 90: 191-4.
4. 4 Polak JF, O'leary DH. Deep venous thrombosis in pregnancy: noninvasive diagnosis. Radiol 1988; 166 (2): 377-9.
5. 5 Hull RD, Raskob GE, Carter CJ. Serial impedance pletysmography in pregnant patients with clinically suspected deep vein thrombosis. Ann Intern Med 1990; 112: 63-7.
6. 6 Hansson P-O, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med 1997; 157: 1665-70.
7. 7 Nordström M, Lindblad B, Bergquist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Int Med 1992; 232: 155-60.
8. 8 Schulman S, Rhedin A-S, Lindmarker P, Carlsson A, Lärfars G, Nicol P, et al. and the Duration of Anticoagulation Trial Study Group. A comparison of six weeks with six months of oral anticoagulant therapy after the first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-5.
9. 9 Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 1995; 92: 2800-2.
10. 10 Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost 1996; 75: 229-32.
11. 11 Eichinger S, Pabinger I, Stüpflen A, Hirschl M, Bialonzyk C, Schneider B, et al. The risk of recurrent venous thromboembolism in patients with and without the factor V Leiden. Thromb Haemost 1997; 77: 624-8.
12. 12 Allaart C, Poort S, Rosendaal F, Reitsma P, Bertina R, Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-8.
13. 13 Emmerich J, Alhenc-Gelas M, Ailaud M-F, Juhan-Vague I, Jude B, Garcin J-M, et al. Clinical features in 36 patients homozygous for the ARG 506→GLN factor V mutation. Thromb Haemost 1997; 77: 620-3.
14. 14 De Stefano V, Leone G., Mastrangelo S, Tripodi A, Rodeghiero F, Castaman G, et al. Clinical manifestations and management if inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 1994; 72: 352-8.
15. 15 Virchow R. Gesammelte Abhandlungen zur Wissenschaftligen Medicin. Frankfurt: A. M. Von Medinger Sohn & Co, 1856.
16. 16 Meissner M, Caps M, Bergelin R, Manzo R, Strandness E. Propagation, rethrombosis and new thrombus formation after acute deep venous thrombosis. J Vasc Surg 1995; 22: 558-67.
17. 17 Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
18. 18 Prandoni P, Lensing AW, Prins M. The natural history of deep-vein thrombosis. Sem Thromb Hemost 1997; 23: 185-8.
19. 19 Jansson J-H, Norberg B, Nilsson TK. Impact of acute phase on concentrations of tissue plasminogen activator and plasminogen activator inhibitor in plasma after deep-vein thrombosis or open-heart surgery. Clin Chem 1989; 35: 1544-5.
20. 20 Schulman S, Svenungsson E, Granqvist S, and the Duration of Anticoagulation Trial Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 1998; 104: 332-8.
21. 21 Kearon C, Julian J, Newman T, Ginsberg J. Noninvasive diagnosis of deep venous thrombosis. Ann Intern Med 1998; 128: 663-77.